GENIE-CV · Autonomous Cardiometabolic AI for Value-Based Care
Autonomous AI for at-risk cardiometabolic care, from data to delivery of value-based care.
GENIE-CV turns claims and clinical data into governed, autonomous action across metabolic risk, cardiac conditions, and MASLD. Built for payviders, ACOs, Medicare Advantage plans, and payers to lift quality and Star ratings, close HEDIS gaps, and prevent readmissions, while clinicians stay in the loop.
- HIPAA & SOC2 Type II
- Co-developed with the American College of Cardiology
- Aligned to the CMS ACCESS Model
Built for At-Risk Entities
For the organizations that carry the risk.
When you are accountable for quality and total cost, cardiometabolic disease is where the risk concentrates. GENIE-CV is built for the entities on the hook for it.
Five-layer observability
Payvider
Payviders
Integrated provider-payer organizations balancing care delivery with medical loss ratio and quality bonuses.
MSSP · REACH
ACOs
Accountable Care Organizations pursuing shared savings, quality benchmarks, and attributed-population performance.
Part C
Medicare Advantage
MA plans whose revenue and reputation ride on Star ratings, HEDIS performance, and member outcomes.
Risk-bearing
Payers
Health plans managing population risk who need real-time gap closure, not retrospective reporting.
Cardiometabolic Scope
One connected model for the conditions that drive the most risk.
Metabolic, cardiac, and liver disease share the same patients and the same data. GENIE-CV reasons across all three on one clinical graph, so nothing falls through the gaps between specialties.
Metabolic Risk Factors
Type 2 diabetes, prediabetes, obesity, hypertension, and dyslipidemia. GENIE-CV surfaces undiagnosed and poorly controlled patients early, before they decompensate.
Cardiac Conditions
Heart failure, coronary artery disease, post-MI care, atrial fibrillation, and hypertension, managed against current American College of Cardiology guidance.
MASLD
Metabolic dysfunction-associated steatotic liver disease, where it is most often missed. GENIE-CV identifies and monitors it across the cardiometabolic population and routes patients to the right pathway.
Closed-Loop Value-Based Care
From data to delivery of value-based care, across the full cardiometabolic journey.
GENIE-CV runs a continuous cycle. Every interaction, claim, and outcome flows back into the clinical graph, so the next intervention is better targeted than the last.
Every closed cycle sharpens risk targeting and quality performance across your attributed population over time.
Value-Based Care Use Cases
Better quality and outcomes, not just lower cost.
Autonomous AI works the measures that decide your VBC performance, so quality, Stars, and patient outcomes improve while readmissions and avoidable utilization fall.
Quality Metrics, HEDIS & Star Ratings
Autonomous gap closure across the measure set that drives quality bonuses and plan ratings, with no added abstraction burden.
- HEDIS gap closure
- Star rating performance
- Quality-bonus eligibility
- Manual chart abstraction
Readmissions & Transitions of Care
Agentic post-discharge follow-up and remote monitoring catch deterioration early and keep transitions from failing.
- 30-day readmissions, upto ~50%
- Transitional care completion
- Avoidable ED revisits
- Post-acute follow-up rate
Patient Outcomes & Engagement
Personalized, omnichannel engagement improves adherence and control of the numbers that matter clinically.
- Medication adherence
- Control of HbA1c, BP, and LDL
- Preventive screening rates
- Patient experience
Risk Identification & Care-Gap Closure
Predictive stratification flags rising risk before costly events, then prioritizes who needs outreach first.
- Early risk identification
- Avoidable admissions
- Shared-savings capture
- Documentation accuracy